Adverse Events Module

Adverse Events Module

For researchers submitting trial data to ClinicalTrials.gov, the Adverse Events module is one of four mandatory results sections. It requires reporting in three primary categories: All-Cause Mortality: A table tracking all deaths that occurred during the study, regardless of cause. Serious Adverse Events (SAEs): A tabular summary of events resulting in death, life-threatening conditions, hospitalization, or significant disability. Other Adverse Events: A table for non-serious events that exceed a specific frequency threshold, such as 5% within any study arm.

Adverse Events Module path is as follows:

Study -> Results Section -> Adverse Events Module -> Event Groups

Study -> Results Section -> Adverse Events Module -> Serious Events

Study -> Results Section -> Adverse Events Module -> Other Events

Adverse Events Module


Ignite Creation Date: 2025-12-24 @ 4:32 PM
Ignite Modification Date: 2025-12-25 @ 2:24 PM
NCT ID: NCT02302066
Description: Safety Analysis Set included all participants who received at least 1 dose of trial vaccine. Data for other (non-serious) adverse events is reported for participants from Immunogenicity Subset with available data for analyses.
Frequency Threshold: 2
Time Frame: All-Cause Mortality and Serious adverse events: From first vaccination (Day 1) through end of study (Day 540); Other adverse events: From any vaccination (Day 1, Day 91, and Day 365) up to 28 days post vaccination.
Study: NCT02302066
Study Brief: Safety and Immunogenicity of Different Schedules of Takeda's Tetravalent Dengue Vaccine Candidate (TDV) in Healthy Participants
Event Groups(If Any):

Event Groups

Title Description Deaths # Affected Deaths # At Risk Serious # Affected Serious # At Risk Other # Affected Other # At Risk View
Group 1 (TDV 2-Dose) Takeda's tetravalent dengue vaccine candidate (TDV), 0.5 mL, subcutaneous injection on Days 1 and 91. Placebo-matching, 0.5 mL, subcutaneous injection on Day 365. 0 None 10 200 17 91 View
Group 2 (TDV 1-Dose) Takeda's TDV, 0.5 mL, subcutaneous injection on Day 1. Placebo-matching, 0.5 mL, subcutaneous injection on Days 91 and 365. 1 None 18 398 43 187 View
Group 3 (TDV 1-Dose + Booster) Takeda's TDV, 0.5 mL, subcutaneous injection on Days 1 and 365. Placebo-matching, 0.5 mL, subcutaneous injection on Day 91. 1 None 65 998 41 191 View
Group 4 (Placebo Control) Placebo-matching, 0.5 mL, subcutaneous injection on Days 1, 91 and 365. 0 None 10 198 22 93 View
Serious Events(If Any):

Serious Events

Term Type Organ System Vocab View
Sinusitis SYSTEMATIC_ASSESSMENT Infections and infestations MedDRA 21.0 View
Tonsillitis SYSTEMATIC_ASSESSMENT Infections and infestations MedDRA 21.0 View
Tooth Abscess SYSTEMATIC_ASSESSMENT Infections and infestations MedDRA 21.0 View
Viral Infection SYSTEMATIC_ASSESSMENT Infections and infestations MedDRA 21.0 View
Contusion SYSTEMATIC_ASSESSMENT Injury, poisoning and procedural complications MedDRA 21.0 View
Head Injury SYSTEMATIC_ASSESSMENT Injury, poisoning and procedural complications MedDRA 21.0 View
Multiple Injuries SYSTEMATIC_ASSESSMENT Injury, poisoning and procedural complications MedDRA 21.0 View
Abdominal Injury SYSTEMATIC_ASSESSMENT Injury, poisoning and procedural complications MedDRA 21.0 View
Ankle Fracture SYSTEMATIC_ASSESSMENT Injury, poisoning and procedural complications MedDRA 21.0 View
Arthropod Bite SYSTEMATIC_ASSESSMENT Injury, poisoning and procedural complications MedDRA 21.0 View
Arthropod Sting SYSTEMATIC_ASSESSMENT Injury, poisoning and procedural complications MedDRA 21.0 View
Burns Second Degree SYSTEMATIC_ASSESSMENT Injury, poisoning and procedural complications MedDRA 21.0 View
Facial Bones Fracture SYSTEMATIC_ASSESSMENT Injury, poisoning and procedural complications MedDRA 21.0 View
Dehydration SYSTEMATIC_ASSESSMENT Metabolism and nutrition disorders MedDRA 21.0 View
Aneurysmal Bone Cyst SYSTEMATIC_ASSESSMENT Musculoskeletal and connective tissue disorders MedDRA 21.0 View
Teratoma Benign SYSTEMATIC_ASSESSMENT Neoplasms benign, malignant and unspecified (incl cysts and polyps) MedDRA 21.0 View
Seizure SYSTEMATIC_ASSESSMENT Nervous system disorders MedDRA 21.0 View
Epilepsy SYSTEMATIC_ASSESSMENT Nervous system disorders MedDRA 21.0 View
Generalised Tonic-Clonic SYSTEMATIC_ASSESSMENT Nervous system disorders MedDRA 21.0 View
Headache SYSTEMATIC_ASSESSMENT Nervous system disorders MedDRA 21.0 View
Migraine SYSTEMATIC_ASSESSMENT Nervous system disorders MedDRA 21.0 View
Relapsing-Remitting Multiple Sclerosis SYSTEMATIC_ASSESSMENT Nervous system disorders MedDRA 21.0 View
Abortion Spontaneous SYSTEMATIC_ASSESSMENT Pregnancy, puerperium and perinatal conditions MedDRA 21.0 View
Premature Baby SYSTEMATIC_ASSESSMENT Pregnancy, puerperium and perinatal conditions MedDRA 21.0 View
Glomerulonephritis Acute SYSTEMATIC_ASSESSMENT Renal and urinary disorders MedDRA 21.0 View
Nephritic Syndrome SYSTEMATIC_ASSESSMENT Renal and urinary disorders MedDRA 21.0 View
Ovarian Cyst SYSTEMATIC_ASSESSMENT Reproductive system and breast disorders MedDRA 21.0 View
Ovarian Cyst Torsion SYSTEMATIC_ASSESSMENT Reproductive system and breast disorders MedDRA 21.0 View
Asthmatic Crisis SYSTEMATIC_ASSESSMENT Respiratory, thoracic and mediastinal disorders MedDRA 21.0 View
Asthma SYSTEMATIC_ASSESSMENT Respiratory, thoracic and mediastinal disorders MedDRA 21.0 View
Bronchospasm SYSTEMATIC_ASSESSMENT Respiratory, thoracic and mediastinal disorders MedDRA 21.0 View
Homicide SYSTEMATIC_ASSESSMENT Social circumstances MedDRA 21.0 View
Finger Amputation SYSTEMATIC_ASSESSMENT Surgical and medical procedures MedDRA 21.0 View
Infectious Colitis SYSTEMATIC_ASSESSMENT Infections and infestations MedDRA 21.0 View
Nasal Abscess SYSTEMATIC_ASSESSMENT Infections and infestations MedDRA 21.0 View
Osteomyelitis SYSTEMATIC_ASSESSMENT Infections and infestations MedDRA 21.0 View
Peritonitis SYSTEMATIC_ASSESSMENT Infections and infestations MedDRA 21.0 View
Peritonsillar Abscess SYSTEMATIC_ASSESSMENT Infections and infestations MedDRA 21.0 View
Pharyngotonsillitis SYSTEMATIC_ASSESSMENT Infections and infestations MedDRA 21.0 View
Pulmonary Tuberculosis SYSTEMATIC_ASSESSMENT Infections and infestations MedDRA 21.0 View
Pyelonephritis SYSTEMATIC_ASSESSMENT Infections and infestations MedDRA 21.0 View
Respiratory Tract Infection SYSTEMATIC_ASSESSMENT Infections and infestations MedDRA 21.0 View
Sepsis SYSTEMATIC_ASSESSMENT Infections and infestations MedDRA 21.0 View
Septic Shock SYSTEMATIC_ASSESSMENT Infections and infestations MedDRA 21.0 View
Constipation SYSTEMATIC_ASSESSMENT Gastrointestinal disorders MedDRA 21.0 View
Vomiting SYSTEMATIC_ASSESSMENT Gastrointestinal disorders MedDRA 21.0 View
Diarrhoea SYSTEMATIC_ASSESSMENT Gastrointestinal disorders MedDRA 21.0 View
Gastritis SYSTEMATIC_ASSESSMENT Gastrointestinal disorders MedDRA 21.0 View
Ileus Paralytic SYSTEMATIC_ASSESSMENT Gastrointestinal disorders MedDRA 21.0 View
Inguinal Hernia SYSTEMATIC_ASSESSMENT Gastrointestinal disorders MedDRA 21.0 View
Intestinal Obstruction SYSTEMATIC_ASSESSMENT Gastrointestinal disorders MedDRA 21.0 View
Volvulus SYSTEMATIC_ASSESSMENT Gastrointestinal disorders MedDRA 21.0 View
Dehiscence SYSTEMATIC_ASSESSMENT General disorders MedDRA 21.0 View
Food Allergy SYSTEMATIC_ASSESSMENT Immune system disorders MedDRA 21.0 View
Hypersensitivity SYSTEMATIC_ASSESSMENT Immune system disorders MedDRA 21.0 View
Amoebic Dysentery SYSTEMATIC_ASSESSMENT Infections and infestations MedDRA 21.0 View
Gastroenteritis SYSTEMATIC_ASSESSMENT Infections and infestations MedDRA 21.0 View
Appendicitis SYSTEMATIC_ASSESSMENT Infections and infestations MedDRA 21.0 View
Pneumonia SYSTEMATIC_ASSESSMENT Infections and infestations MedDRA 21.0 View
Urinary Tract Infection SYSTEMATIC_ASSESSMENT Infections and infestations MedDRA 21.0 View
Abscess Limb SYSTEMATIC_ASSESSMENT Infections and infestations MedDRA 21.0 View
Ascariasis SYSTEMATIC_ASSESSMENT Infections and infestations MedDRA 21.0 View
Dengue Fever SYSTEMATIC_ASSESSMENT Infections and infestations MedDRA 21.0 View
Scarlet Fever SYSTEMATIC_ASSESSMENT Infections and infestations MedDRA 21.0 View
Amoebiasis SYSTEMATIC_ASSESSMENT Infections and infestations MedDRA 21.0 View
Appendicitis Perforated SYSTEMATIC_ASSESSMENT Infections and infestations MedDRA 21.0 View
Bronchitis SYSTEMATIC_ASSESSMENT Infections and infestations MedDRA 21.0 View
Burkholderia Cepacia Complex Sepsis SYSTEMATIC_ASSESSMENT Infections and infestations MedDRA 21.0 View
Encephalomyelitis SYSTEMATIC_ASSESSMENT Infections and infestations MedDRA 21.0 View
Endometritis SYSTEMATIC_ASSESSMENT Infections and infestations MedDRA 21.0 View
Gastroenteritis Rotavirus SYSTEMATIC_ASSESSMENT Infections and infestations MedDRA 21.0 View
Hepatitis A SYSTEMATIC_ASSESSMENT Infections and infestations MedDRA 21.0 View
Immune Thrombocytopenic Purpura SYSTEMATIC_ASSESSMENT Blood and lymphatic system disorders MedDRA 21.0 View
Ocular Myasthenia SYSTEMATIC_ASSESSMENT Eye disorders MedDRA 21.0 View
Other Events(If Any):

Other Events

Term Type Organ System Vocab View
Vomiting SYSTEMATIC_ASSESSMENT Gastrointestinal disorders MedDRA 21.0 View
Pyrexia SYSTEMATIC_ASSESSMENT General disorders MedDRA 21.0 View
Diarrhoea SYSTEMATIC_ASSESSMENT Gastrointestinal disorders MedDRA 21.0 View
Hypersensitivity SYSTEMATIC_ASSESSMENT Immune system disorders MedDRA 21.0 View
Nasopharyngitis SYSTEMATIC_ASSESSMENT Infections and infestations MedDRA 21.0 View
Viral Infection SYSTEMATIC_ASSESSMENT Infections and infestations MedDRA 21.0 View
Bronchitis SYSTEMATIC_ASSESSMENT Infections and infestations MedDRA 21.0 View
Tonsillitis SYSTEMATIC_ASSESSMENT Infections and infestations MedDRA 21.0 View
Parasitic Gastroenteritis SYSTEMATIC_ASSESSMENT Infections and infestations MedDRA 21.0 View
Headache SYSTEMATIC_ASSESSMENT Nervous system disorders MedDRA 21.0 View
Nasal Congestion SYSTEMATIC_ASSESSMENT Respiratory, thoracic and mediastinal disorders MedDRA 21.0 View
Gastroenteritis SYSTEMATIC_ASSESSMENT Infections and infestations MedDRA 21.0 View